DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: A subset of congenital muscular dystrophies in humans (including MDDGA11), called dystroglycanopathies, is characterized by a reduced glycosylation of α-dystroglycan (α-DG), which is an integral component of the dystrophin glycoprotein complex.